Janus Henderson Group plc 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 12:21 pm Sale | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 700,100 1.300% | -2,357,206 (-77.10%) | Filing |
| 2023-02-10 11:26 am Purchase | 2022-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 3,057,306 7.600% | 61,866 (+2.07%) | Filing |
| 2022-02-10 4:49 pm Sale | 2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 2,995,440 7.400% | -643,398 (-17.68%) | Filing |
| 2021-02-12 3:42 pm Purchase | 2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 3,638,838 9.100% | 3,638,838 (New Position) | Filing |